Characteristic | CHD cases (n = 435) | Controls (n = 274) |
---|---|---|
Age at recruitment | 61 ± 8.9 | 59 ± 9.6 |
Men | 365 (83.9) | 129 (47.1) |
BMI -- kg/m2 | 28 ± 3.5 | 27 ± 5.3 |
≥ 30 kg/m2 | 103 (23.7) | 49 (17.9) |
Medication | ||
Verapamil | 220 (50.6) | -- |
Placebo | 215 (49.4) | -- |
Event | ||
Intracoronary stent | 362 (83.2) | -- |
Previous CABG | 17 (3.9) | -- |
Previous PTCA | 43 (9.9) | -- |
Previous MI | 156 (35.9) | -- |
Cardiovascular risk factor | ||
Diabetes mellitus | 54 (12.4) | 22 (8.0) |
Hypertension | 279 (64.1) | 139 (50.7) |
Hyperlipidaemia | 373 (85.7) | 138 (50.4) |
Current smoker | 103 (23.7) | 40 (14.6) |
Former smoker | 163 (37.5) | 47 (17.2) |
Family history of CHD | 166 (38.2) | n/a |
Restenosis | 128 (29.4) | -- |